Rare diseases
Investigational molecules
Locations
Back to Portugal214 clinical trials in Braga, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
PortugalStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
PortugalA study to evaluate how cytisinicline works in patients with nicotine addiction and kidney problems or those undergoing dialysis
PortugalPortugalA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
PortugalStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
PortugalStudy of ABBV-CLS-628 to evaluate safety and effectiveness in adults with Autosomal Dominant Polycystic Kidney Disease
PortugalStudy on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
PortugalStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PortugalStudy on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy
PortugalStudy on the Effect of Pancreatic Enzyme Replacement Therapy with Pancreas Powder in Patients with Pancreatic Exocrine Insufficiency After Total Gastrectomy
PortugalStudy on Atogepant for Preventing Menstrual Migraine in Women
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for multiple sclerosis, including chronic neuropathic pain management and new therapeutic approaches. Research also encompasses frontotemporal dementia and various types of migraines.
Studies focus on both symptom management and disease modification approaches.
Comprehensive research into various skin conditions, including plaque psoriasis, atopic dermatitis, and hidradenitis suppurativa. Clinical trials are evaluating new biological treatments and long-term management strategies.
Focus on developing targeted therapies for chronic skin conditions.
Investigation of novel treatments for autoimmune conditions, including studies on lupus nephritis and immune thrombocytopenia. Research aims to develop more effective therapeutic approaches.
Emphasis on innovative immunological interventions and targeted therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
